Comment
doi: 10.1016/S1474-4422(23)00125-4.
New therapies for autoimmune myasthenia gravis
Affiliations
- PMID: 37059497
- DOI: 10.1016/S1474-4422(23)00125-4
Item in Clipboard
Comment
New therapies for autoimmune myasthenia gravis
Lancet Neurol.
2023 May.
Erratum in
-
Correction to Lancet Neurol 2023; 22: 368-69.Lancet Neurol. 2023 Jun;22(6):e8. doi: 10.1016/S1474-4422(23)00173-4. Lancet Neurol. 2023. PMID: 37210102 No abstract available.
No abstract available
Conflict of interest statement
JJGMV has been involved in myasthenia gravis research sponsored by the Princes Beatrix Fonds, Health Holland, and consults for argenx, Alexion, and NMD Pharma. Reimbursements for this work were received by the LUMC. JJGMV is coinventor on patent applications based on MuSK-related research, for which the LUMC receives royalties for MuSK antibody assays. JJGMV is a member of the European Reference Network for Rare Neuromuscular Diseases and Target-to-B! consortium.
Comment on
-
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
-
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
Similar articles
-
Autoimmune mechanisms in myasthenia gravis.Curr Opin Neurol. 2012 Oct;25(5):621-9. doi: 10.1097/WCO.0b013e328357a829. Curr Opin Neurol. 2012. PMID: 22941261 Review.
-
Current pharmacotherapeutic options for myasthenia gravis.Expert Opin Pharmacother. 2019 Dec;20(18):2295-2303. doi: 10.1080/14656566.2019.1682548. Epub 2019 Oct 31. Expert Opin Pharmacother. 2019. PMID: 31670984 Review.
-
Management of juvenile myasthenia gravis.Pediatr Neurol. 2013 Feb;48(2):95-104. doi: 10.1016/j.pediatrneurol.2012.07.008. Pediatr Neurol. 2013. PMID: 23337001 Review.
-
Drug related crisis in myasthenia gravis.J Assoc Physicians India. 2006 Oct;54:820-1. J Assoc Physicians India. 2006. PMID: 17214282
-
Medical treatment options for ocular myasthenia gravis.Curr Opin Ophthalmol. 2008 Nov;19(6):468-78. doi: 10.1097/ICU.0b013e328310da18. Curr Opin Ophthalmol. 2008. PMID: 18854691 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
